The effects of vaped cannabis on the severity of naloxone-precipitated opioid withdrawal.
Authors
- Jeanne M. Manubay
- Felipe Castillo (ORCID: https://orcid.org/0000-0001-7362-9043)
- Rachel Luba (ORCID: https://orcid.org/0000-0003-3404-766X)
- Caroline A. Arout (ORCID: https://orcid.org/0000-0003-0444-6432)
- Suky Martinez (ORCID: https://orcid.org/0000-0002-4873-8130)
- Freymon Perez
- Jermaine D. Jones (ORCID: https://orcid.org/0000-0003-4476-2800)
- Sandra D. Comer
- Margaret Haney (ORCID: https://orcid.org/0000-0002-1220-9528)
Institutions
- Behavioral Pharma (United States) (US)
- British Columbia Centre on Substance Use (CA)
Publication Details
- Journal
- Experimental and Clinical Psychopharmacology
- Published
- 2025-08-21
- DOI
- https://doi.org/10.1037/pha0000796
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Institute on Drug Abuse